Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis

Rationale: There is an urgent need for simple, cost-effective prognostic biomarkers for idiopathic pulmonary fibrosis (IPF); biomarkers that show potential include monocyte count. Objectives: We used pooled data from pirfenidone and IFNγ-1b trials to explore the association between monocyte count an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreuter, Michael, Lee, Joyce S., Tzouvelekis, Argyrios, Oldham, Justin M., Molyneaux, Philip L., Weycker, Derek, Atwood, Mark, Kirchgaessler, Klaus-Uwe, Maher, Toby M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437112/
https://www.ncbi.nlm.nih.gov/pubmed/33434107
http://dx.doi.org/10.1164/rccm.202003-0669OC

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437112/
https://www.ncbi.nlm.nih.gov/pubmed/33434107
http://dx.doi.org/10.1164/rccm.202003-0669OC

Ejemplares similares